Roche and Synta Pharmaceuticals entered an agreement potentially worth $1.025 billion to discover, develop, and commercialize small molecule anti-inflammatories. Roche will pay Synta $25 million upfront, which includes $9 million in research funding ...
Read more...
Helping adolescents with arthritis develop the skills and secure resources to assure that their health care needs are met as they transition to adulthood is an important issue in the U.S. In general, the frequency of which young people with special ...
Read more...
Ann Arbor-based Velcura Therapeutics Inc. said Wednesday that it had completed its second successful Investigational New Drug application to the United States Food and Drug Administration for its lead compound, VEL-0230. The November 2008 IND filing ...
Read more...
CHAPEL HILL, NC—Attorney Sheila Mikhail is once again showing that raising venture money is not the only way to get a promising start up going, even in the money-hungry field of biotech. Not only that, sometimes, all that’s necessary to improve ...
Read more...
CHICAGO, Jan 7 (Reuters) - A drug used to suppress the immune system in cancer and rheumatoid arthritis has helped extend the life of a Minnesota boy struggling with a rare and deadly form of the genetic disorder Pompe disease. A team of researchers ...
Read more...
A: Salmonellosis is an infection with a bacteria called salmonella. Most persons infected with salmonella develop diarrhea, fever, and abdominal cramps 12 to 72 hours after infection. The illness usually lasts 4 to 7 days, and most persons recover ...
Read more...
Total knee replacement (TKR) is a common treatment for osteoarthritis, a disease affecting more than 20 million Americans. However, the surgery poses risks and both patients and physicians must carefully assess its potential benefits and harm ...
Read more...